Other languages Emergent BioSolutions Inc.

Equities

EBS

US29089Q1058

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
1.92 ^USD	-1.54%		-11.11%	-20.00%

Apr. 24	Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise	MT
Mar. 25	Emergent Gets FDA's 'No Action Indicated' Status For Baltimore Bayview Manufacturing Facility	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise	Apr. 24
Emergent Gets FDA's 'No Action Indicated' Status For Baltimore Bayview Manufacturing Facility	Mar. 25
Emergent Biosolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility	Mar. 25
Sector Update: Health Care Stocks Rise Late Afternoon	Mar. 12
Sector Update: Health Care Stocks Higher in Afternoon Trading	Mar. 12
Emergent BioSolutions Tumbles After S&P Global Credit Downgrade	Mar. 12
Emergent BioSolutions Inc. Provides Revenue Guidance for the First Quarter and Earnings Guidance for the Full Year of 2024	Mar. 06
Emergent BioSolutions Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06
Emergent BioSolutions Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 06
Sector Update: Health Care Stocks Mixed in Late Afternoon	Feb. 21
Top Midday Gainers	Feb. 21
Emergent appoints former Bausch + Lomb CEO to head company	Feb. 21
Emergent BioSolutions Appoints Joseph C. Papa as President	Feb. 21
Emergent BioSolutions Inc. Announces Changes in CEO	Feb. 21
High-dose opioid reversal spray no better than lower dose in field, US study finds	Feb. 08
Emergent extends shelf life of opioid overdose reversal drug Narcan	Jan. 17
Emergent Biosolutions Awarded Contract to Provide BioThrax to US Military	Jan. 11
Emergent BioSolutions Receives Procurement Contract to Supply BioThrax (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense	Jan. 11
Tech firms, Wall Street lead job cuts in Corporate America	Dec. 04
Sector Update: Health Care Stocks Ease Tuesday Afternoon	Nov. 28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Emergent BioSolutions Inc.

Equities

EBS

US29089Q1058

Other languages

Filters